Shadowdweller
Graduate Poster
- Joined
- Mar 22, 2008
- Messages
- 1,509
They're relevant to individuals or meta-studies claiming that mass numbers of people become no longer transgendered. Seeing as subjects can change between those categories. Or move to and from places where physicians and mental health workers diagnose (/bill) the conditions differently. Or simply stop particular billable interventions without ceasing to identify as or be transgendered.Individuals who identify as transgender but do not seek diagnosis and treatment are of some interest to this thread but of little interest to medical journals. Individuals who seek diagnosis and treatment for gender dysphoria but do not identify as transgender are of interest to medical journals but not really on topic here in this thread.
Hormone therapy needs to be kept up. Not all the other types of therapy do. And again, the dysphoria itself may be eliminated or temporarily absent from a particular time period. This is particularly relevant given that the study this particular chain of discussion revolves around included some children who were significantly younger than would typically receive hormone therapy.If the pharmacological interventions must be consistently kept up in order to prevent the patient from physically detransitioning towards their birth sex, then the psychiatric ICD-10 diagnosis F64 must be kept up as well so as to keep the money moving from the insurers to the doctors and pharmacies supplying the needs of the patients. This is where your appendicitis analogy fails quite spectacularly, since appendectomy is typically a one-off billing event.
Last edited: